Not yet taking people in EgyptNo phase
Blood Count Measures in Acute Lymphoblastic Leukemia Patients
Studies whether blood count measures predict response to induction chemotherapy in leukemia.
Plain-language title generated from the registry record
Registry title: Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
Key facts
- Where
- Sohag, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 5 and 50 years old?
Source: NCT06746571, who can take part
Where in Egypt
- Sohag University HospitalSohag, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sohag University
- Trial code
- NCT06746571
- Record updated
- 24 December 2024
- Original description
Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapyRead full original descriptionShow less
Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients
Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy
Inclusion: patients newly diagnosed ALL.
Exclusion: ALL on therapy; others malignanices.